News Daily News Prevention Efforts Seem to Be Paying Off as Acute MIs Continue Slide Todd Neale August 08, 2016
News Daily News Los Esfuerzos en Materia de Prevención Empiezan a Dar sus Frutos Con Índices IAM en Descenso Todd Neale August 08, 2016
News Daily News Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution Yael L. Maxwell August 03, 2016
News Daily News Broader, Primary Prevention Role for High-Sensitivity Troponin Tests Suggested by ARIC Analysis Shelley Wood June 10, 2016
News Daily News La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad Michael O'Riordan May 17, 2016
News Daily News Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates Michael O'Riordan May 17, 2016
News Daily News New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin Caitlin E. Cox March 23, 2016
News Industry News New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control March 01, 2016
News Daily News Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI Yael L. Maxwell December 22, 2015
News Daily News El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM Yael L. Maxwell December 22, 2015
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Industry News New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets June 19, 2015